What is the risk of extrapyramidal symptoms in patients taking aripiprazole?

Josh Scheil, David Power

Family Medicine and Community Health (Twin Cities)

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	28-29
Number of pages	2
Journal	Evidence-Based Practice
Volume	26
Issue number	2
DOIs	https://doi.org/10.1097/ebp.0000000000001733
State	Published - Feb 2023

Publisher link

10.1097/ebp.0000000000001733

https://journals.lww.com/10.1097/EBP.0000000000001733

Find It

Find It at U of M Libraries

Other files and links

Cite this

@article{5de9a81d7a5b49ca99a094da2a4c7510,

title = "What is the risk of extrapyramidal symptoms in patients taking aripiprazole?",

author = "Josh Scheil and David Power",

year = "2023",

month = feb,

doi = "10.1097/ebp.0000000000001733",

language = "English (US)",

volume = "26",

pages = "28--29",

journal = "Evidence-Based Practice",

issn = "1095-4120",

publisher = "Dowden Health Media,Inc",

number = "2",

}

TY - JOUR

T1 - What is the risk of extrapyramidal symptoms in patients taking aripiprazole?

AU - Scheil, Josh

AU - Power, David

PY - 2023/2

Y1 - 2023/2

UR - http://www.scopus.com/inward/record.url?scp=85148206061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148206061&partnerID=8YFLogxK

U2 - 10.1097/ebp.0000000000001733

DO - 10.1097/ebp.0000000000001733

M3 - Comment/debate

SN - 1095-4120

VL - 26

SP - 28

EP - 29

JO - Evidence-Based Practice

JF - Evidence-Based Practice

IS - 2

ER -